Last reviewed · How we verify

Botulinum toxin A 100u

EvergreenHealth · FDA-approved active Small molecule Quality 5/100

Botulinum toxin A 100u is a Small molecule drug developed by EvergreenHealth. It is currently FDA-approved. Also known as: BOTOX®, OnabotulinumtoxinA.

At a glance

Generic nameBotulinum toxin A 100u
Also known asBOTOX®, OnabotulinumtoxinA
SponsorEvergreenHealth
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Botulinum toxin A 100u

What is Botulinum toxin A 100u?

Botulinum toxin A 100u is a Small molecule drug developed by EvergreenHealth.

Who makes Botulinum toxin A 100u?

Botulinum toxin A 100u is developed and marketed by EvergreenHealth (see full EvergreenHealth pipeline at /company/evergreenhealth).

Is Botulinum toxin A 100u also known as anything else?

Botulinum toxin A 100u is also known as BOTOX®, OnabotulinumtoxinA.

What development phase is Botulinum toxin A 100u in?

Botulinum toxin A 100u is FDA-approved (marketed).

Related